December 12, 2022
Emmes launches cell and gene therapy centre
Emmes, a global, full-service clinical research organization (CRO) dedicated to supporting the advancement of public…
December 12, 2022
Updated: Gilead, Arcellx team up on anti-BCMA CAR-T as biotech touts a 100% response rate at #ASH22 – Endpoints News
Gilead and Kite are plunking down big cash to get into the anti-BCMA CAR-T game.…
December 12, 2022
Arcellx and Kite Announce Strategic Collaboration to Co-Develop and Co-Commercialize Late-Stage Clinical CART-ddBCMA in Multiple Myeloma
REDWOOD CITY, Calif., and SANTA MONICA, Calif., Dec. 9, 2022 /PRNewswire/ -- Arcellx, Inc. (NASDAQ:…
December 9, 2022
Maryland Inno – Baltimore biotech Haystack Oncology raises $56M, plans move to City Garage
The Johns Hopkins University researchers behind two of Baltimore's most successful biotech firms have founded…
December 8, 2022
New UMD biotech campus to open in Montgomery County in 2023
The University of Maryland is partnering with Montgomery County to develop a new biotech campus…
December 8, 2022
Emmes Launches Cell and Gene Therapy Center
Decades of Experience and Emerging Opportunities Led to its Creation ROCKVILLE, Md., Dec. 8, 2022…
December 8, 2022
United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2023
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., December 08, 2022--(BUSINESS WIRE)--United Therapeutics (Nasdaq: UTHR),…
December 6, 2022
536th Edition, December 6, 2022
Trouble Viewing This Email: Click Here December 6, 2022 FOUNDING MEMBER OF EIR…
December 6, 2022
536th Edition, December 6, 2022
Trouble Viewing This Email: Click Here December 6, 2022 FOUNDING MEMBER OF EIR…